Ernexa Therapeutics Inc. (ERNA) vs Gelteq Limited Ordinary Shares (GELS)
A side-by-side comparison of Ernexa Therapeutics Inc. and Gelteq Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ERNA
Ernexa Therapeutics Inc.
$2.28HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
GELS
Gelteq Limited Ordinary Shares
$0.57HealthcareDelayed quote: Oct 6, 2026, 2:13 PM EDT
Total return — ERNA vs GELS
growth of $100 · dividends reinvested · last 2yERNA -99.2% (-91.1%/yr)GELS -81.5% (-57.0%/yr)GELS compounded faster over this window
Log scale — wide-divergence pair
ERNA GELS
ERNA vs GELS: by the numbers
- •GELS is the larger company ($5M vs $4M market cap).
- •Both run net losses; ERNA's is the smaller (0.00% vs -4011.86% net margin).
Metrics side by side
Valuation
| Metric | ERNA | GELS |
|---|---|---|
| P/B ratio | 1.16 | 0.55 |
Profitability
| Metric | ERNA | GELS |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -3317.65% |
| Net margin | 0.00% | -4011.86% |
| ROE | -383.03% | -42.05% |
| ROIC | -346.94% | -27.41% |
Growth (annualized)
| Metric | ERNA | GELS |
|---|---|---|
| Total return CAGR (5Y) | -86.83% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.